Compound directory
50 of 50 compounds
BPC-157
ProtocolBody Protection Compound-157
- Start
- 0.25 mg
- Freq.
- Once or twice daily
- Vials
- 5 / 10 mg
TB-500
ProtocolThymosin Beta-4 fragment
- Start
- 2 mg
- Freq.
- 2× weekly (loading), then weekly
- Vials
- 5 / 10 mg
Tirzepatide
ProtocolGIP / GLP-1 dual agonist
- Start
- 2.5 mg
- Freq.
- Once weekly
- Vials
- 10 / 15 / 30 mg
Retatrutide
ProtocolGIP / GLP-1 / glucagon triple agonist
- Start
- 2 mg
- Freq.
- Once weekly
- Vials
- 10 / 20 / 30 mg
Semaglutide
ProtocolGLP-1 agonist
- Start
- 0.25 mg
- Freq.
- Once weekly
- Vials
- 3 / 5 / 10 mg
CJC-1295 / Ipamorelin
BlendGHRH + GHRP blend (no DAC)
5 mg CJC-1295 (no DAC) · 5 mg Ipamorelin
Per vial · verified against reference guide
- Start
- 0.1 mg each
- Freq.
- Once daily, before bed, 5 days on / 2 off
- Vials
- 10 mg
Ipamorelin
Protocol- Start
- 0.1 mg
- Freq.
- 1–3× daily
- Vials
- 5 / 10 mg
GHK-Cu
ProtocolCopper tripeptide-1
- Start
- 1 mg
- Freq.
- Once daily
- Vials
- 50 / 100 mg
Epitalon
ProtocolEpithalon, AEDG
- Start
- 5 mg
- Freq.
- Once daily
- Vials
- 10 / 50 mg
MOTS-c
Protocol- Start
- 5 mg
- Freq.
- 1–2× weekly
- Vials
- 10 / 40 mg
Semax
Protocol- Start
- 0.3 mg
- Freq.
- 1–2× daily
- Vials
- 5 / 10 mg
Selank
Protocol- Start
- 0.25 mg
- Freq.
- 1–2× daily
- Vials
- 5 / 10 mg
Wolverine Blend
BlendBPC-157 + TB-500
10 mg BPC-157 · 10 mg TB-500
Per vial · verified against reference guide
- Start
- 0.5 mg total blend
- Freq.
- Once daily
- Vials
- 20 mg
GLOW
BlendGHK-Cu + BPC-157 + TB-500
50 mg GHK-Cu · 10 mg TB-500 · 10 mg BPC-157
Per vial · verified against reference guide
- Start
- ~1.6 mg total blend
- Freq.
- Once daily
- Vials
- 70 mg
KLOW
BlendKPV + GHK-Cu + BPC-157 + TB-500
50 mg GHK-Cu · 10 mg TB-500 · 10 mg BPC-157 · 10 mg KPV
Per vial · verified against reference guide
- Start
- ~1.8 mg total blend
- Freq.
- Once daily
- Vials
- 80 mg
Tesamorelin
ProtocolGHRH analog
- Vials
- 10 / 20 mg
- Data
- Lab reference
Cagrilintide
ProtocolLong-acting amylin analog
- Vials
- 5 mg
- Data
- Lab reference
CJC-1295 DAC
ProtocolGHRH analog with Drug Affinity Complex
- Vials
- 2 mg
- Data
- Lab reference
NAD+
ProtocolNicotinamide adenine dinucleotide
- Vials
- 500 / 1000 mg
- Data
- Lab reference
AOD-9604
ProtocolhGH fragment 176-191 analog
- Vials
- 2 / 5 mg
- Data
- Lab reference
5-Amino-1MQ
ProtocolNNMT inhibitor
- Vials
- 10 / 50 mg
- Data
- Lab reference
AICAR
ProtocolAcadesine
- Vials
- 50 mg
- Data
- Lab reference
Adamax
ProtocolSemax analog
- Vials
- 10 mg
- Data
- Lab reference
Cagrilintide + Semaglutide
BlendCagriSema
5 mg Cagrilintide · 5 mg Semaglutide
Per vial · verified against reference guide
- Vials
- 10 mg
- Data
- Lab reference
CJC-1295 + GHRP-2
Blend5 mg CJC-1295 · 5 mg GHRP-2
Per vial · verified against reference guide
- Vials
- 10 mg
- Data
- Lab reference
Ipamorelin + Tesamorelin
Blend5 mg Tesamorelin · 5 mg Ipamorelin
Per vial · verified against reference guide
- Vials
- 10 mg
- Data
- Lab reference
AOD-9604 + CJC-1295 + Ipamorelin
Blend6 mg AOD-9604 · 3 mg CJC-1295 · 3 mg Ipamorelin
Per vial · verified against reference guide
- Vials
- 12 mg
- Data
- Lab reference
Tri-Heal
BlendTB-500 + BPC-157 + KPV
25 mg TB-500 · 10 mg BPC-157 · 10 mg KPV
Per vial · verified against reference guide
- Vials
- 45 mg
- Data
- Lab reference
ARA-290
ProtocolCibinetide
- Vials
- 10 mg
- Data
- Lab reference
PT-141
ProtocolBremelanotide
- Vials
- 10 mg
- Data
- Lab reference
Cartalax
ProtocolAED tripeptide
- Vials
- 10 / 20 mg
- Data
- Lab reference
DSIP
ProtocolDelta sleep-inducing peptide
- Vials
- 5 / 10 mg
- Data
- Lab reference
FOXO4-DRI
Protocol- Vials
- 10 mg
- Data
- Lab reference
GHRP-6
ProtocolGrowth hormone releasing peptide-6
- Vials
- 5 / 10 mg
- Data
- Lab reference
Glutathione
ProtocolGSH
- Vials
- 500 / 1000 mg
- Data
- Lab reference
Humanin
Protocol- Vials
- 10 mg
- Data
- Lab reference
IGF-1 LR3
ProtocolLong R3 IGF-1
- Vials
- 1 mg
- Data
- Lab reference
Kisspeptin-10
ProtocolKp-10
- Vials
- 10 mg
- Data
- Lab reference
KPV
Protocolα-MSH(11-13)
- Vials
- 10 mg
- Data
- Lab reference
Melanotan II
ProtocolMT-II
- Vials
- 10 mg
- Data
- Lab reference
Oxytocin
Protocol- Vials
- 2 / 5 mg
- Data
- Lab reference
Sermorelin
ProtocolGHRH(1-29)
- Vials
- 5 / 10 mg
- Data
- Lab reference
SLU-PP-332
ProtocolERR agonist
- Vials
- 5 / 10 mg
- Data
- Lab reference
SS-31
ProtocolElamipretide
- Vials
- 10 / 50 mg
- Data
- Lab reference
Survodutide
ProtocolGLP-1 / glucagon dual agonist
- Vials
- 10 / 20 mg
- Data
- Lab reference
Tesofensine
Protocol- Vials
- 10 mg
- Data
- Lab reference
Thymosin Alpha-1
ProtocolTα1
- Vials
- 5 / 10 mg
- Data
- Lab reference
VIP
ProtocolVasoactive intestinal peptide
- Vials
- 5 / 10 mg
- Data
- Lab reference
Cagrilintide + Tirzepatide
Stack- Vials
- 10 mg
- Data
- Lab reference
Cagrilintide + Retatrutide
Stack- Vials
- 10 mg
- Data
- Lab reference